Viewing Study NCT00240032


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2025-12-25 @ 7:36 PM
Study NCT ID: NCT00240032
Status: COMPLETED
Last Update Posted: 2011-04-11
First Post: 2005-10-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-10
Start Date Type: None
Primary Completion Date: 2006-06
Primary Completion Date Type: ACTUAL
Completion Date: 2006-07
Completion Date Type: ACTUAL
First Submit Date: 2005-10-13
First Submit QC Date: None
Study First Post Date: 2005-10-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2011-04-07
Last Update Post Date: 2011-04-11
Last Update Post Date Type: ESTIMATED